Pharmaceutical Policy in Countries with Developing Healthcare Systems
- Publisher's listprice EUR 160.49
-
66 563 Ft (63 393 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 313 Ft off)
- Discounted price 53 250 Ft (50 714 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
66 563 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1st ed. 2017
- Publisher Springer International Publishing
- Date of Publication 4 April 2017
- Number of Volumes 1 pieces, Book
- ISBN 9783319516721
- Binding Hardback
- No. of pages430 pages
- Size 235x155 mm
- Weight 8668 g
- Language English
- Illustrations XII, 430 p. 36 illus., 33 illus. in color. Illustrations, black & white 0
Categories
Long description:
A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
MoreTable of Contents:
1. Introduction.- Section I: Low and Lower Middle Income Countries.- 2. Pharmaceutical Policy in the East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania.- 3. Pharmaceutical Policy in Pakistan.- 4. Pharmaceutical Policy in Philippines.- 5. Pharmaceutical Policy in Vietnam.- Section II: Upper Middle Income Countries.- 6. Pharmaceutical Policy in Argentina.- 7. Pharmaceutical Policy in Brazil.- 8. Pharmaceutical Policy In Bulgaria.- 9. Pharmaceutical Policy in China.- 10. Pharmaceutical Policy in Colombia.- 11. Pharmaceutical Policy in Ecuador.- 12. Pharmaceutical Policy in Jordan.- 13. Pharmaceutical Policy in Russia.- 14. Pharmaceutical Policy in South Africa.- Section III: High Income Countries.- 15. Pharmaceutical Policy in Poland.- 16. Pharmaceutical Policy in Saudi Arabia.- 17. Pharmaceutical Policy in Trinidad and Tobago.- 18. Pharmaceutical Policy in United Arab Emirates.- Section IV: Further Perspectives.- 19. ‘Repurposing’ Medicines: a Case for Low- and Middle-Income Countries with Developing Healthcare Systems.- 20. Pharmaceutical Policy in Countries with Developing Healthcare Systems: Synthesis of Country Case Studies.
More
Frommer's? London 2002
6 205 HUF
5 585 HUF
Antonio Candido: On Literature and Society
6 683 HUF
6 015 HUF
